Fulcrum Therapeutics, Inc.
2020 Q1 - 2025 Q4 (24 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/13/2026 | 4,398 | 0.0% | 388,896 | 12/31/2025 |
| 2025 Q3 | 11/10/2025 | 3,068 | 0.0% | 333,483 | 9/30/2025 |
| 2025 Q2 | 8/12/2025 | 2,668 | 0.0% | 387,782 | 6/30/2025 |
| 2025 Q1 | 9/15/2025 | 1,098 | 0.0% | 381,359 | 3/31/2025 |
| 2024 Q4 | 2/6/2025 | 2,472 | 0.0% | 526,045 | 12/31/2024 |
| 2024 Q3 | 11/12/2024 | 2,032 | 0.0% | 569,185 | 9/30/2024 |
| 2024 Q2 | 8/12/2024 | 1,091 | 0.0% | 175,983 | 6/30/2024 |
| 2024 Q1 | 5/9/2024 | 231 | 0.0% | 24,485 | 3/31/2024 |
| 2023 Q4 | 2/6/2024 | 165 | 0.0% | 24,485 | 12/31/2023 |
| 2023 Q3 | 11/8/2023 | 109 | 0.0% | 24,485 | 9/30/2023 |
| 2023 Q2 | 8/10/2023 | 81 | 0.0% | 24,485 | 6/30/2023 |
| 2023 Q1 | 5/12/2023 | 403 | 0.0% | 141,311 | 3/31/2023 |
| 2022 Q4 | 2/13/2023 | 836 | 0.0% | 114,887 | 12/31/2022 |
| 2022 Q3 | 11/14/2022 | 751 | 0.0% | 92,771 | 9/30/2022 |
| 2022 Q2 | 8/15/2022 | 422 | 0.0% | 85,919 | 6/30/2022 |
| 2022 Q1 | 5/13/2022 | 1,708 | 0.0% | 72,209 | 3/31/2022 |
| 2021 Q4 | 2/11/2022 | 1,247 | 0.0% | 70,485 | 12/31/2021 |
| 2021 Q3 | 11/16/2021 | 1,900 | 0.0% | 67,348 | 9/30/2021 |
| 2021 Q2 | 8/16/2021 | 569 | 0.0% | 54,284 | 6/30/2021 |
| 2021 Q1 | 5/17/2021 | 514 | 0.0% | 43,630 | 3/31/2021 |
| 2020 Q4 | 2/16/2021 | 434 | 0.0% | 37,014 | 12/31/2020 |
| 2020 Q3 | 11/13/2020 | 260 | 0.0% | 32,708 | 9/30/2020 |
| 2020 Q2 | 8/20/2020 | 546 | 0.0% | 29,798 | 6/30/2020 |
| 2020 Q1 | 5/15/2020 | 320 | 0.0% | 26,769 | 3/31/2020 |